1. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study.
- Author
-
Ali, Sasha Saadia, R, Naveen, Sen, Parikshit, Day, Jessica, Joshi, Mrudula, Nune, Arvind, Nikiphorou, Elena, Saha, Sreoshy, Tan, Ai Lyn, Shinjo, Samuel Katsuyuki, Ziade, Nelly, Velikova, Tsvetelina, Milchert, Marcin, Jagtap, Kshitij, Parodis, Ioannis, Gracia-Ramos, Abraham Edgar, Cavagna, Lorenzo, Kuwana, Masataka, Knitza, Johannes, and Chen, Yi Ming
- Subjects
BIOTHERAPY ,STATISTICS ,INTENSIVE care units ,COVID-19 ,CONFIDENCE intervals ,CROSS-sectional method ,SELF-evaluation ,COVID-19 vaccines ,MULTIVARIATE analysis ,AUTOIMMUNE diseases ,JOINT pain ,DISEASE relapse ,RISK assessment ,COMPARATIVE studies ,SURVEYS ,SEVERITY of illness index ,CHI-squared test ,DESCRIPTIVE statistics ,HOSPITAL care ,OXYGEN therapy ,MYOSITIS ,DATA analysis software ,ODDS ratio ,HYDROXYCHLOROQUINE ,LONGITUDINAL method ,COMORBIDITY ,DISEASE risk factors - Abstract
The article presents a study which analysed predictors in a global sample of patients with idiopathic inflammatory myopathies (IIMs) using data from the second COVID-19 Vaccination in Autoimmune Diseases (COVAD) study. Topics include patients included in the study, patient-reported flares following COVID-19 infection among IIM patients, and factors that were found to significantly increase the risk of flares in univariate analysis.
- Published
- 2023
- Full Text
- View/download PDF